rs41291971

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000289.6(PFKM):​c.2087G>A​(p.Arg696His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0141 in 1,613,446 control chromosomes in the GnomAD database, including 185 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R696C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.010 ( 11 hom., cov: 32)
Exomes 𝑓: 0.014 ( 174 hom. )

Consequence

PFKM
NM_000289.6 missense

Scores

3
9
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 9.94

Publications

22 publications found
Variant links:
Genes affected
PFKM (HGNC:8877): (phosphofructokinase, muscle) Three phosphofructokinase isozymes exist in humans: muscle, liver and platelet. These isozymes function as subunits of the mammalian tetramer phosphofructokinase, which catalyzes the phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate. Tetramer composition varies depending on tissue type. This gene encodes the muscle-type isozyme. Mutations in this gene have been associated with glycogen storage disease type VII, also known as Tarui disease. Alternatively spliced transcript variants have been described.[provided by RefSeq, Nov 2009]
PFKM Gene-Disease associations (from GenCC):
  • glycogen storage disease VII
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000289.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009243131).
BP6
Variant 12-48145125-G-A is Benign according to our data. Variant chr12-48145125-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 255756.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0105 (1597/152328) while in subpopulation NFE AF = 0.0179 (1216/68030). AF 95% confidence interval is 0.017. There are 11 homozygotes in GnomAd4. There are 711 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000289.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PFKM
NM_000289.6
MANE Select
c.2087G>Ap.Arg696His
missense
Exon 21 of 23NP_000280.1P08237-1
PFKM
NM_001354735.1
c.2396G>Ap.Arg799His
missense
Exon 24 of 26NP_001341664.1A0A2R8Y891
PFKM
NM_001354736.1
c.2396G>Ap.Arg799His
missense
Exon 24 of 26NP_001341665.1A0A2R8Y891

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PFKM
ENST00000359794.11
TSL:1 MANE Select
c.2087G>Ap.Arg696His
missense
Exon 21 of 23ENSP00000352842.5P08237-1
PFKM
ENST00000312352.11
TSL:1
c.2087G>Ap.Arg696His
missense
Exon 21 of 23ENSP00000309438.7P08237-1
PFKM
ENST00000547587.5
TSL:1
c.2087G>Ap.Arg696His
missense
Exon 20 of 22ENSP00000449426.1P08237-1

Frequencies

GnomAD3 genomes
AF:
0.0105
AC:
1596
AN:
152210
Hom.:
11
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00309
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00726
Gnomad ASJ
AF:
0.00518
Gnomad EAS
AF:
0.00173
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.00820
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0179
Gnomad OTH
AF:
0.00860
GnomAD2 exomes
AF:
0.00969
AC:
2436
AN:
251424
AF XY:
0.00960
show subpopulations
Gnomad AFR exome
AF:
0.00289
Gnomad AMR exome
AF:
0.00596
Gnomad ASJ exome
AF:
0.00516
Gnomad EAS exome
AF:
0.00163
Gnomad FIN exome
AF:
0.00730
Gnomad NFE exome
AF:
0.0160
Gnomad OTH exome
AF:
0.00978
GnomAD4 exome
AF:
0.0145
AC:
21175
AN:
1461118
Hom.:
174
Cov.:
31
AF XY:
0.0140
AC XY:
10211
AN XY:
726922
show subpopulations
African (AFR)
AF:
0.00206
AC:
69
AN:
33474
American (AMR)
AF:
0.00624
AC:
279
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00524
AC:
137
AN:
26128
East Asian (EAS)
AF:
0.000806
AC:
32
AN:
39698
South Asian (SAS)
AF:
0.00248
AC:
214
AN:
86244
European-Finnish (FIN)
AF:
0.00760
AC:
406
AN:
53416
Middle Eastern (MID)
AF:
0.00208
AC:
12
AN:
5768
European-Non Finnish (NFE)
AF:
0.0174
AC:
19354
AN:
1111298
Other (OTH)
AF:
0.0111
AC:
672
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
1039
2079
3118
4158
5197
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
724
1448
2172
2896
3620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0105
AC:
1597
AN:
152328
Hom.:
11
Cov.:
32
AF XY:
0.00954
AC XY:
711
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.00308
AC:
128
AN:
41576
American (AMR)
AF:
0.00725
AC:
111
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00518
AC:
18
AN:
3472
East Asian (EAS)
AF:
0.00173
AC:
9
AN:
5190
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4828
European-Finnish (FIN)
AF:
0.00820
AC:
87
AN:
10610
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0179
AC:
1216
AN:
68030
Other (OTH)
AF:
0.00851
AC:
18
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
75
151
226
302
377
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0147
Hom.:
77
Bravo
AF:
0.00965
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
Glycogen storage disease, type VII (5)
-
-
4
not provided (4)
-
-
3
not specified (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
-0.089
T
BayesDel_noAF
Uncertain
0.12
CADD
Pathogenic
32
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.47
T
Eigen
Uncertain
0.61
Eigen_PC
Uncertain
0.64
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.96
D
MetaRNN
Benign
0.0092
T
MetaSVM
Uncertain
-0.053
T
MutationAssessor
Uncertain
2.5
M
PhyloP100
9.9
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-2.2
N
REVEL
Pathogenic
0.65
Sift
Benign
0.061
T
Sift4G
Benign
0.099
T
Varity_R
0.63
gMVP
0.82
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs41291971;
hg19: chr12-48538908;
COSMIC: COSV100402319;
COSMIC: COSV100402319;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.